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In vivo assembly of DNA-fragments 
in the moss, Physcomitrella patens
Brian Christopher King1,*, Konstantinos Vavitsas1,*, Nur Kusaira Binti Khairul Ikram1,2,3,*, 
Josephine Schrøder1, Lars B. Scharff1, Björn Hamberger1, Poul Erik Jensen1 & 
Henrik Toft Simonsen3
Direct assembly of multiple linear DNA fragments via homologous recombination, a phenomenon 
known as in vivo assembly or transformation associated recombination, is used in biotechnology to 
assemble DNA constructs ranging in size from a few kilobases to full synthetic microbial genomes. 
It has also enabled the complete replacement of eukaryotic chromosomes with heterologous DNA. 
The moss Physcomitrella patens, a non-vascular and spore producing land plant (Bryophyte), has a 
well-established capacity for homologous recombination. Here, we demonstrate the in vivo assembly 
of multiple DNA fragments in P. patens with three examples of effective genome editing: we (i) 
efficiently deleted a genomic locus for diterpenoid metabolism yielding a biosynthetic knockout, (ii) 
introduced a salt inducible promoter, and (iii) re-routed endogenous metabolism into the formation of 
amorphadiene, a precursor of high-value therapeutics. These proof-of-principle experiments pave the 
way for more complex and increasingly flexible approaches for large-scale metabolic engineering in 
plant biotechnology.
P. patens has been used for decades to study plant metabolic engineering1. The dominant phase of the life cycle 
is haploid, so backcrossing to establish homozygous transgenic lines is not necessary1. In addition, the genome 
has been fully sequenced2. The unique capacity of P. patens among plants for efficient homologous recombination 
has established P. patens as a model organism, especially for studies concerning the elucidation of gene function 
and the colonization of terrestrial ecosystems by plants2–5. Moreover, P. patens is used in biotechnology as a 
heterologous expression host for recombinant therapeutic proteins and small natural products of commercial 
value1,6–9. Plant specific glycosylation patterns can be immunogenic for injected therapeutics, however P. patens 
has been be precisely engineered to alter the glycosylation pattern of the recombinant proteins making them 
more human-like, thus providing an advantage to P. patens-derived therapeutics1,6. P. patens can grow in liquid 
cultures and large bioreactors in its filamentous haploid vegetative state that assures homogeneity and reproduc-
ibility of production10. Finally, P. patens, as a photosynthetic organism, has a high potential as biotechnological 
host, especially in cases when: the availability of light-dependent reduction equivalents is critical; the presence of 
subcellular compartments (such as plastids, mitochondria, and vacuoles) can be exploited for creating tailored 
microenvironments; and as an expression system for plant biosynthetic pathways11–13. Further development of 
genetic engineering methodologies could help to increase the power and potential of the platform.
Polyethylene glycol (PEG) mediated transformation of P. patens protoplasts with a single linearized plasmid 
is a standard method of introducing heterologous DNA into cells of P. patens14,15. P. patens also permits targeting 
of multiple insertion sites in one single transformation event16, and the homologous recombination efficiency is 
comparable to the yeast Saccharomyces cerevisiae17. Targeted integration in the nuclear genome typically utilizes 
homologous sequences between the genome and inserted DNA of 500 bases or longer14.However, it has been 
previously demonstrated in P. patens that episomal recombination events can occur in a reproducible and pre-
dictable manner, guided by as few as a 12 bases of homology18. We therefore investigated whether the homolo-
gous recombination machinery of P. patens can be utilized to assemble and integrate DNA fragments with short 
overlapping sequences. When the assembled multi-fragment construct contains 5′ and 3′ flanking sequences 
with homology to the P. patens genome, it integrates in the genome in a targeted manner, similar to the typical 
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transformation with a linearized vector. The short length requirement for efficient homologous recombination 
is a significant technological advance, since short (12–20) base overlaps are convenient to incorporate into PCR 
primers. Complex in vivo assembly of multiple DNA fragments is a routine procedure using S. cerevisiae, con-
tributing greatly to its extensive use as a synthetic biology and biotechnology host19–21, therefore the development 
of a similar methodology for P. patens can further increase its utility as a plant biotechnological chassis. Here, we 
explore direct PEG transformation of P. patens using PCR products containing short overlapping sequences, and 
show that it is a robust method for genome engineering.
Results and Discussion
To demonstrate uptake, assembly, and correct genomic integration of multiple DNA fragments in moss, we 
focused on three examples of P. patens transformation related to plant biotechnology. We utilized our published 
vector pBK3 that was established in order to study terpenoid biosynthesis through the knock-out of the native P. 
patens bifunctional copalyl diphosphate/kaurene synthase (CPS/KS) gene7,22,23. The vector replaces CPS/KS with 
the gene for the enhanced yellow fluorescent protein variant SEYFP-F46L (Venus)24 under hygromycin selection 
(Fig. 1a). Using this vector as a template, we amplified three DNA sequences (Fig. 1b) that cover the whole insert 
region, each having a sequence overlap with the one next to it. Four different overhang lengths (12, 20, 50, and 
100 base pairs) were examined.
A correct transformation event results in stable P. patens lines that have three distinct phenotypes. They are 
resistant to hygromycin, express Venus from the CPS/KS promoter, and lack ent-kaurene derived diterpenes 
(Fig. 1c,d). We transformed P. patens with linear pBK3 vector and with equimolar amounts of the PCR fragments 
produced from the same vector. All the PCR fragments were also transformed individually as negative controls 
(Supplemental Fig. 1). As the coding sequences of both the Venus reporter and the hygromycin resistance are 
split on different DNA fragments, and none of the fragments contain a full-length coding sequence, the DNA 
repair system of P. patens must assemble the three fragments via homologous recombination to gain all the phe-
notypes described above. We recovered 12–21 (Table 1) antibiotic resistant lines for the different transformation 
approaches, the linear vector-transformation and the in vivo assembly (Fig. 1c). We then screened all of these 
resistant lines for fluorescent protein expression. Transformations using single fragments did not result in plants 
expressing Venus or surviving antibiotic selection. Accumulation of Venus was observed in both protonemal tis-
sue (Fig. 1c) and gametophores (Supplemental Fig. 2). However, accumulation of Venus was only observed in rap-
idly dividing cells, such as protonemal tips and the core of the gametophore, tissue giving rise to the sporophyte. 
This suggests that the CPS/KS enzyme and ent-kaurene related metabolites are associated with cell division and 
differentiation, providing further insights in the functionality of ent-kaurenes in P. patens and other bryophytes. 
We performed metabolite profiling of the fluorescent lines, and confirmed the lack of detectable diterpenoids in 
6–11 lines using the different transformation approaches (Table 1, Fig. 1d). In order to verify the correct insertion 
of the transgenes, we genotyped the lines that were both fluorescent and lacking ent-kaurenes, (Fig. 1e). Sequence 
information was obtained for the regions where the DNA assembly occurred. Two fully genotyped lines were 
recovered showing the appropriate phenotypes with linear vector-transformation and 4 lines of the different 
in vivo assembly approaches, the fragments were correctly assembled and integrated in the targeted genetic locus, 
and lacked the native CPS/KS gene. The correctly integrated and assembled transformants (for both linear vector 
and multi-fragment transformation) correspond to 10–22% of the antibiotic resistant lines. The transformation 
results and the number of obtained lines are summarized in Table 1.
We also generated two novel constructs that were designed for integration in the well-established neutral locus 
Pp108 that allows efficient genomic integration in P. patens3. Here, we amplified the overlapping DNA fragments, 
adding 27–30 base overhangs via PCR primers for transformation without pre-assembly of vectors in E. coli. As 
inducible systems are valuable for tuning of heterologous expression, we studied the P. patens sodium induci-
ble promoter, PpENA125 with Venus as a reporter gene. For selection, this three-fragment assembly encoded a 
geneticin (G418) resistance (nptII) cassette (Supplemental Fig. 3). We obtained 32 fluorescent lines, of which six 
were assembled correctly. The promoter activity was measured in plants growing on media supplemented with 
NaCl (0–100 mM). We observed NaCl induced Venus expression (Fig. 2a), which reached a plateau at a concen-
tration of 60 mM NaCl (Fig. 2b). These results are consistent with previously reported data on this promoter25.
Finally, we expressed the gene for the amorphadiene synthase AaADS, a sesquiterpene synthase from 
Artemisia annua that catalyzes the first committed step of the biosynthesis of the antimalarial drug artemisinin26. 
AaADS was expressed coupled to Venus using the LP4 linker (a linker peptide from a polyprotein precursor of 
Impatiens balsamina, which results in expression of two separate proteins27,28). The promoter driving the fused 
genes was the UBIQUITIN1 promoter from Zea mays (ZmUBI1), and the selection was again based on geneticin 
resistance. Collectively, these PCR products gave a four-fragment assembly (Supplemental Fig. 4). We analyzed 
the 10 lines showing antibiotic resistance for yellow fluorescence (Fig. 2c), and we subjected the resulting 9 flu-
orescent lines to GC-MS analysis to confirm biosynthesis of amorphadiene by the AaADS (Fig. 2d). Correct 
insertions in the Pp108 locus and assembly of both the PpENA1 and the AaADS constructs were confirmed for 
three independent lines via genotyping. Assembly and integration were tested by PCR-based genotyping and 
sequence-verification (Supplemental Figs 5 and 6). In these cases, assembly was demonstrated by appropriate 
phenotypes and PCR confirmation of internal junctions, however genomic integration could not be verified. 
This suggests the possibility that assembled DNA was maintained episomally, without integration to the genome.
In all three transformation experiments, we acquired plant lines that contain the desired genomic sequence, 
assembled correctly and inserted in the targeted genomic locus (Table 1). The evaluation of the transformant 
phenotypes was performed sequentially, i.e. resistant lines were screened for fluorescence, followed by metabolite 
profiling using GC-MS, before genotyping. The transformation efficiency and correct integration were similar for 
the multi-fragment transformations and the traditional transformation using a linearized vector. Previous studies 
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Figure 1. Knockout of the native diterpene synthase CPS/KS gene. (a) A vector map of the linearized pBK3 
vector, including 1000 bp both 5′ and 3′ of the native CPS/KS coding sequence. The 5′ region contains the 
1491 bp of the region upstream the ATG for this diterpene synthase gene fused to the gene for the fluorescent 
protein, Venus. Resistance to hygromycin was conferred by aminoglycoside phosphotransferase 4 coded 
by aph4 under expression from the 35S promoter. Arrows indicate locations of primer pairs used for PCR 
genotyping. All genetic maps were created using the software OG Draw (http://ogdraw.mpimp-golm.mpg.de/). 
(b) Depiction of the three PCR fragments amplified from pBK3, of sizes 2.3, 1.9, and 1.4 kb. (c) Microscopy of 
Ppcps/ks knockout plants. From left to right: Bright-field, chlorophyll fluorescence (590–680 nm) and Venus 
fluoresence (520–560 nm). (d) GC-MS analysis of WT P. patens and a multi-fragment transformation resulting 
in the absence of the two major diterpenes found in hexane extractions, 16-ent-kaurene (1) and 16-OH-ent-
kaurene (2). (e) Proper insertion and in vivo assembly of DNA fragments were confirmed by PCR. Primer pair 
1 (P13 andP14) only binds in a region of DNA specific to the wild type (WT) CPS/KS locus, and gives a band 
of 778 bp only if the WT locus is intact. This band is absent in the three shown transformed lines, including a 
linearized plasmid transformant, a 50 bp overlap transformant, and a 12 bp overlap transformant. The primer pairs 
2 (P14, P5), 3 (P3, P4) and 4 (P13, P2) give sizes of 1421 bp, 1882 bp, and 2372 bp respectively, indicating proper 
assembly of fragments and insertion in the genome. The PCR products were sequence-verified.
www.nature.com/scientificreports/
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indicated that the specific targeted locus and the presence of repeating elements are possibly more important 
determinants of the transformation efficiency than the length of the homology regions17,29.
Previous studies also reported incomplete and non-targeted integration. Episomal concatamers and tandem 
insertions are common events, and were suggested as result from non-homologous end-joining. In addition, 
one-sided integration and random insertions were described18,29,30. Consistent with such non-targeted and 
incomplete integration events, we observed antibiotic resistant plant lines lacking one or more of the independent 
phenotypes used (Table 1). However, the three examples of transformation presented here demonstrate the ability 
of P. patens to take up, assemble and correctly integrate up to 9.2 kilobases of DNA directly into the genomic tar-
get site. This new transformation technology provides an easy way to assemble DNA fragments in a plant system, 
minimizing the need for laborious sub-cloning and gene construction in E. coli or S. cerevisiae vectors. Moreover, 
using this technique allows for flexible genome editing, combinatorial assembly of DNA parts, and engineering of 
complex metabolic pathways, which are all important for high-throughput synthetic biology studies.
Improved techniques for targeted, controlled, and large-scale genome manipulation of plant systems are 
highly valuable and could facilitate understanding and improving genetic structure and function at the chromo-
some and genome levels. P. patens is already extensively used for both basic research and applied biotechnology. 
The implementation and optimization of in vivo DNA assembly methodologies can significantly improve the 
potential of P. patens as a biotechnological host species and as a photosynthetic chassis for synthetic biology.
Methods
Plant material. P. patens (Gransden ecotype, International Moss Stock Center #40001) was grown on solid 
PhyB media14,15, in a growth chamber, at 25 °C with 16/8 h light/dark cycle, 20–50 W/m2 light intensity.
Transformation of P. patens protoplasts. Protoplasts were prepared and transformed using a stand-
ard PEG method14,15. More precisely, approximately 1.5 g in fresh weight (three Petri dishes) of 5 days cultured 
P. patens was digested with a 0.5% Driselase® enzyme solution in 8.5% mannitol (Sigma D9515), using one ml 
of solution for every 40 mg P. patens tissue and incubated with gentle agitation for 30–60 minutes at room tem-
perature. The digested tissue was filtered through mesh with pore size of 100 μ m. Protoplasts were pelleted by 
centrifuging at 150–200 × g for 5 minutes with slow breaking. The supernatant was discarded and the pellet was 
washed twice with protoplast wash solution (8.5% mannitol, 10 mM CaCl2). Protoplast density was measured 
using a hemocytometer, followed by centrifuging and resuspension in MMM solution (9.1% D-mannitol, 10% 
MES and 15mM MgCl2) giving a protoplast concentration of 1.6 × 106 cells/mL. 300 μ L of protoplast suspension 
and 300 μ L of PEG solution were added to a 15 mL tube containing the DNA. For both linearized plasmid and 
multi-fragment transformations, 20 μ g total DNA was used. For the multi-fragment transformations, fragments 
were added in an equimolar ratio.
The mixture was incubated in a 45 °C water bath for 5 minutes and another 5 minutes at room temperature. 
Samples were diluted 5 times by adding 300 μ L of 8.5% D-mannitol with 1 min pauses between dilutions, followed 
by an additional 5 dilutions with 1 mL of 8.5% D-mannitol. The transformed protoplasts were pelleted by centrif-
ugation and the supernatant was discarded. The protoplast pellet was resuspended in 500 μ L of 8.5% D-mannitol 
and 2.5 mL of protoplast regeneration media (top layer; PRMT). 1 ml of the suspension was dispensed on each 
plate (three plates in total) containing protoplast regeneration media (bottom layer; PRMB) overlaid with a cel-
lophane disc. The plates were incubated for 5–7 days. The cellophane with regenerating protoplasts was then 
transferred on PhyB media containing appropriate selection for two weeks.
Transformations were moved to media without antibiotics for another two weeks to allow loss of unstable and 
non-integrated DNA, and then plants were moved back to a final antibiotic selection for two weeks at which point 
they were considered stable. A detailed protocol can be found in references14,15.
DNA parts and genes. Genomic sequences and annotations of P. patens were retrieved form cosmoss.org. 
The pBK3 vector7 was used to generate the Ppcps/ks-knockout plants. The PpENA1 promoter and the homologous 
recombination flanking regions of the Pp108 locus were amplified from P. patens genomic DNA. The AaADS 
Resistant 
lines
Fluorescent 
lines
GC-MS 
positive 
lines
Genotype-
positive linesa
Efficacy 
[%]b
linearized pBK3 20 14 6 2 10.0
In vivo assembly pBK3 
(12 bp overlap) 25 21 11 4 16.0
In vivo assembly pBK3 
(20 bp overlap) 18 14 6 4 22.2
In vivo assembly pBK3 
(50 bp overlap) 27 19 9 4 14.8
In vivo assembly pBK3 
(100 bp overlap) 19 12 8 4 21.1
PpENA1-Venus 32 32 c 6 18.8
AaADS 10 9 7 3 30.0
Table 1.  Number of P. patens lines generated in this work and comparison of transformation efficiency. 
aPlant lines, in which the native locus replacement and proper assembly were confirmed. bDefined as genotype-
positive/resistant lines. cNo product was expected for the PpENA-Venus transformants.
www.nature.com/scientificreports/
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template was a kind gift from Assoc. Prof. Dae Kyun Ro, University of Calgary, Canada. The ZmUBI1 promoter 
was obtained from the pMP1355 vector, a kind gift from Professor Mark Estelle, University of California San 
Diego, USA.
PCR, DNA purification and concentration. Polymerase chain reactions (PCR) were performed using 
Phusion® High-Fidelity DNA Polymerase (New England Biolabs) or Hotmaster Taq (5PRIME) according to 
provider’s protocol. The primers used are listed in Supplemental Table 1. PCR products for transformations or 
sequencing were purified using the QIAquick PCR Purification Kit (Qiagen), according to manufacturer’s proto-
col. Purified DNA for transformations was vacuum-concentrated in a ScanVac vacuum concentrator (LaboGene) 
to a final DNA concentration of ~1 μ g/μ L determined spectrophotometrically using NanoDrop2000 (Thermo 
Fisher Scientific).
Microscopy. Transformed P. patens lines were screened using a stereo microscope (Leica MZ FLII Stereo 
Fluorescence Microscope) and a fluorescence source (Leica DN 5000B Fluorescence Microscope). The Ppcps/ks 
knockout lines were sub-cultured on solid PhyB media while the PpENA1 lines were sub-cultured on media 
Figure 2. Transformation of P. patens with the endogenous salt-inducible promoter, ena1, and the 
amorphadiene synthase gene ADS from Artemisia annua, targeted to the neutral site Pp108. (a) Venus 
fluorescence after 24 h induction of PpENA1-Venus expression with 20 mM, 60 mM, and 100 mM NaCl (0 mM 
was used as negative control) was observed in both protonemal tissue and gametophores. Three fluorescent 
wavelengths were tested (from left to right): Bright field, chlorophyll fluorescence (590–680 nm), and Venus 
fluorescence (520–560 nm). (b) Graph showing the fluorescent intensity of Venus, after the expression of its gene 
was induced by different salt concentrations. (c) Fluorescence of AaADS-Venus. From left to right: UV light (350–
420 nm), chlorophyll fluorescence (590–680 nm) and Venus fluorescence (Venus) (520–560 nm). (d) GC-MS 
analysis of amorphadiene (1) produced from transgenic P. patens with mass spectra and retention time.
www.nature.com/scientificreports/
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containing NaCl (0 mM (non induced), 20 mM, 60 mM, and 100 mM) with wild-type as a control. Micrographs 
were captured 24 hours after induction. Fluorescence intensity of approximately 25 replicates from each treatment 
was quantified with the software program Fiji (ImageJ).
The Ppcps/ks knockout and PpENA1-Venus lines were further analyzed with a Leica TCS SP5 II spectral confo-
cal laser-scanning microscope (Leica Microsystems, Heidelberg, Germany). The fluorescence was quantified with 
a 63x/1.2 numerical aperture water immersion objective for the detection of yellow fluorescence. A sequential 
scanning was performed for the PpENA1 lines, to detect the fluorescence of the Venus protein, whose expres-
sion was driven by the inducible PpENA1 promoter. The excitation was set at 488 nm allowing for the detection 
of chlorophyll at 590–680 nm. This was followed by excitation 515 nm that allow for the detection of Venus at 
520–560 nm. The maximum intensity was set as the relative fluorescence exhibited from cells treated with 100 mM 
NaCl.
Metabolite profiling. The metabolite profile of the transgenic lines was examined using a Shimadzu 
GCMS-QP2010 Plus (GC-2010). Samples were prepared as previously described14. To screen for biochemical 
knockouts, one microliter of hexane extract was injected in split-less mode and separated with HP-5MS UI col-
umn (20.0 m × 0.18 mm × 0.18 μ m) with hydrogen as a carrier gas. The GC program was as follows: 60 °C for 
3 min, 60~150 °C at 30 °C/min, 150~210 °C at 10 °C/min, 210~320 °C at 30 °C/min and was held for 5 min. The 
profile of AaADS lines was determined by HS-SPME (Headspace-Solid Phase Micro-Extraction)31,32. The identity 
of amorphadiene and ent-kaurene was confirmed by comparison of the obtained mass spectrum and retention 
index with those found in the literature33 and the NIST 08 and Wiley 8.0 libaries.
DNA isolation. DNA for PCR analysis was isolated as previously described34, with minor modifications. 
Briefly, fresh P. patens tissue (approximately 10–20 mg) was collected in 1.5 ml microfuge tubes, frozen in liquid 
nitrogen, then ground using a plastic pestle. 400 μ L of extraction buffer (50 mM Tris·HCl pH 8.0 and 20 mM 
EDTA pH 8.0) was added followed by 80 μ l of 10% SDS. The mixture was gently vortexed and incubated at 65 °C 
for 30 min. 180 μ L of 3M NaAc pH 5.2 was added to the mixture and samples were incubated on ice for 20 min. 
Samples were centrifuged at 15,000 × g for 10 min to pellet debris. The supernatant was transferred to a new tube 
containing an equal volume of isopropanol and was mixed by inversion. DNA was pelleted by centrifugation at 
15,000 × g for 30 min. The supernatant was discarded and the pellet was washed with 80% ethanol and allowed to 
air dry before the final resuspension in 50 μ L water.
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